Reporting to the Sr. Medical Director, Oncology, this role will have primary responsibility for new clinical trials with the Company’s primary clinical asset, IMO-2125. This role provides medical direction and high quality scientific and clinical knowledge to guide the strategy and execution of Idera’s clinical development plan. This role works collaboratively with multi-disciplinary teams responsible for the design, implementation, monitoring, analysis, and reporting of studies conducted within Idera’s immuno-oncology portfolio to ensure the program meets the needs of patients and Idera’s business. This role will influence both internal and external audiences in a high impact, highly visible role as it actively contributes to the dynamic and innovative culture within Idera.
Education & Experience Requirements
Other Job Requirements